{"data":[{"accessionNo":"0001973379-26-000342","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Savage Brian","relationship":"Officer, CHIEF LEGAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":7028,"aggregateMarketValue":273062.13,"unitsOutstanding":11166292643,"approxSaleDate":"2026-09-18","exchange":"NYSE","filedAt":"2026-09-21"},{"accessionNo":"0000919574-26-006400","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Bridger Management, LLC (1)","relationship":"Shareholder","securityClass":"Ordinary Shares","broker":"Apex Clearing Corporation","unitsToSell":367600,"aggregateMarketValue":14406244,"unitsOutstanding":1166292643,"approxSaleDate":"2026-09-18","exchange":"NYSE","filedAt":"2026-09-18"},{"accessionNo":"0001973379-26-000296","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Lippman Evan","relationship":"Officer, EVP BUSINESS DEVELOPMENT","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":18600,"aggregateMarketValue":680291.39,"unitsOutstanding":1165296084,"approxSaleDate":"2026-08-17","exchange":"NYSE","filedAt":"2026-08-17"},{"accessionNo":"0001973379-26-000273","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Jover Placid","relationship":"Executive VP, Chief HR Officer","securityClass":"Ordinary Shares","broker":"Citigroup Global Markets, Inc","unitsToSell":12827,"aggregateMarketValue":447350.6,"unitsOutstanding":1165296084,"approxSaleDate":"2026-08-03","exchange":"NYSE","filedAt":"2026-08-03"},{"accessionNo":"0001973379-26-000274","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Hughes Eric A","relationship":"Executive VP Global R&D and Chief Med Officer","securityClass":"Ordinary Shares","broker":"Citigroup Global Markets, Inc","unitsToSell":25578,"aggregateMarketValue":892050.65,"unitsOutstanding":1165296084,"approxSaleDate":"2026-08-03","exchange":"NYSE","filedAt":"2026-08-03"},{"accessionNo":"0001973379-26-000248","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Shields Matthew","relationship":"Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":9989,"aggregateMarketValue":321546.91,"unitsOutstanding":1164426972,"approxSaleDate":"2026-06-18","exchange":"NYSE","filedAt":"2026-06-18"},{"accessionNo":"0001973379-26-000227","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Kalif Eliyahu Sharon","relationship":"Officer, EVP CHIEF FINANCIAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":106563,"aggregateMarketValue":3633304.91,"unitsOutstanding":1164426972,"approxSaleDate":"2026-06-11","exchange":"NYSE","filedAt":"2026-06-11"},{"accessionNo":"0001973379-26-000222","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Francis Richard D","relationship":"Officer, PRESIDENT AND CEO","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":6153,"aggregateMarketValue":211355.55,"unitsOutstanding":1164426972,"approxSaleDate":"2026-06-05","exchange":"NYSE","filedAt":"2026-06-05"},{"accessionNo":"0001973379-26-000220","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Shields Matthew","relationship":"Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":16195,"aggregateMarketValue":532329.65,"unitsOutstanding":1164426972,"approxSaleDate":"2026-06-03","exchange":"NYSE","filedAt":"2026-06-03"},{"accessionNo":"0001973379-26-000178","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Lippman Evan","relationship":"Officer, EXECUTIVE VP BUSINESS DEVELOPMENT","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":41658,"aggregateMarketValue":1482366.6,"unitsOutstanding":1164426972,"approxSaleDate":"2026-05-14","exchange":"NYSE","filedAt":"2026-05-14"},{"accessionNo":"0001973379-26-000177","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Kalif Eliyahu Sharon","relationship":"Officer, EVP CHIEF FINANCIAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":153251,"aggregateMarketValue":5457368.64,"unitsOutstanding":1164426972,"approxSaleDate":"2026-05-14","exchange":"NYSE","filedAt":"2026-05-14"},{"accessionNo":"0001973379-26-000156","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Daniell Richard","relationship":"Officer, EXECUTIVE VP EUROPEAN COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":30000,"aggregateMarketValue":1062000,"unitsOutstanding":1164426972,"approxSaleDate":"2026-05-05","exchange":"NYSE","filedAt":"2026-05-05"},{"accessionNo":"0001973379-26-000154","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Sabag Mark","relationship":"Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":144180,"aggregateMarketValue":5045122.63,"unitsOutstanding":1164426972,"approxSaleDate":"2026-05-01","exchange":"NYSE","filedAt":"2026-05-04"},{"accessionNo":"0001973379-26-000116","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Sabag Mark","relationship":"Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":62102,"aggregateMarketValue":1871815.26,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-17","exchange":"NYSE","filedAt":"2026-03-17"},{"accessionNo":"0001973379-26-000092","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Shields Matthew","relationship":"Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":17295,"aggregateMarketValue":547704.98,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-05","exchange":"NYSE","filedAt":"2026-03-05"},{"accessionNo":"0001973379-26-000090","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Savage Brian","relationship":"Officer, INTERIM CHIEF LEGAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":1127,"aggregateMarketValue":35690.24,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-05","exchange":"NYSE","filedAt":"2026-03-05"},{"accessionNo":"0001973379-26-000091","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Jover Placid","relationship":"Officer, EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":14150,"aggregateMarketValue":448107.86,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-05","exchange":"NYSE","filedAt":"2026-03-05"},{"accessionNo":"0001973379-26-000087","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Hughes Eric A","relationship":"Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":9533,"aggregateMarketValue":301894.86,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-05","exchange":"NYSE","filedAt":"2026-03-05"},{"accessionNo":"0001973379-26-000088","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Francis Richard D","relationship":"Officer, PRESIDENT AND CEO","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":20025,"aggregateMarketValue":634159.7,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-05","exchange":"NYSE","filedAt":"2026-03-05"},{"accessionNo":"0001973379-26-000089","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Fox Christine","relationship":"Officer, EVP HEAD OF US COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":7924,"aggregateMarketValue":250940.4,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-05","exchange":"NYSE","filedAt":"2026-03-05"},{"accessionNo":"0001973379-26-000086","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Daniell Richard","relationship":"Officer, EXECUTIVE VP EUROPEAN COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":17295,"aggregateMarketValue":547704.98,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-05","exchange":"NYSE","filedAt":"2026-03-05"},{"accessionNo":"0001973379-26-000083","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Hughes Eric A","relationship":"Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":11277,"aggregateMarketValue":366102.17,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-04","exchange":"NYSE","filedAt":"2026-03-04"},{"accessionNo":"0001973379-26-000084","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Francis Richard D","relationship":"Officer, PRESIDENT AND CEO","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":23393,"aggregateMarketValue":759442.05,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-04","exchange":"NYSE","filedAt":"2026-03-04"},{"accessionNo":"0001973379-26-000085","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Fox Christine","relationship":"Officer, EVP HEAD OF US COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":9908,"aggregateMarketValue":321658.26,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-04","exchange":"NYSE","filedAt":"2026-03-04"},{"accessionNo":"0001973379-26-000082","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Daniell Richard","relationship":"Officer, EXECUTIVE VP EUROPEAN COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":91345,"aggregateMarketValue":2983515.95,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-04","exchange":"NYSE","filedAt":"2026-03-04"},{"accessionNo":"0001973379-26-000076","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Savage Brian","relationship":"Officer, EXECUTIVE VP INTERIM CHIEF LEGAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":1274,"aggregateMarketValue":41226.51,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-03","exchange":"NYSE","filedAt":"2026-03-03"},{"accessionNo":"0001973379-26-000074","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Hughes Eric A","relationship":"Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":80762,"aggregateMarketValue":2613450.24,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-03","exchange":"NYSE","filedAt":"2026-03-03"},{"accessionNo":"0001973379-26-000075","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Francis Richard D","relationship":"Officer, PRESIDENT AND CEO","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":442935,"aggregateMarketValue":14333332.31,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-03","exchange":"NYSE","filedAt":"2026-03-03"},{"accessionNo":"0001973379-26-000073","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Daniell Richard","relationship":"Officer, EXECUTIVE VP EUROPEAN COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":128985,"aggregateMarketValue":4173941.7,"unitsOutstanding":1149812898,"approxSaleDate":"2026-03-03","exchange":"NYSE","filedAt":"2026-03-03"},{"accessionNo":"0001973379-26-000052","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Kalif Eliyahu Sharon","relationship":"Officer, EVP CHIEF FINANCIAL OFFICER","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":345810,"aggregateMarketValue":11634702.06,"unitsOutstanding":1149812898,"approxSaleDate":"2026-02-26","exchange":"NYSE","filedAt":"2026-02-26"},{"accessionNo":"0001973379-26-000039","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Francis Richard D","relationship":"Officer, PRESIDENT AND CEO","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS","unitsToSell":447778,"aggregateMarketValue":15324798,"unitsOutstanding":1149812898,"approxSaleDate":"2026-02-17","exchange":"NYSE","filedAt":"2026-02-18"},{"accessionNo":"0001973379-26-000038","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Francis Richard D","relationship":"Officer, PRESIDENT AND CEO","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":447778,"aggregateMarketValue":447778,"unitsOutstanding":15324798,"approxSaleDate":"2026-02-17","exchange":"NYSE","filedAt":"2026-02-18"},{"accessionNo":"0000902664-25-005281","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Bridger Management, LLC (1)","relationship":"Shareholder","securityClass":"American Depositary Shares","broker":"Piper Sandler & Co.","unitsToSell":150000,"aggregateMarketValue":4527000,"unitsOutstanding":1147282512,"approxSaleDate":"2025-12-12","exchange":"NYSE","filedAt":"2025-12-12"},{"accessionNo":"0001973379-25-000316","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Sabag Mark","relationship":"Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":216892,"aggregateMarketValue":6230750,"unitsOutstanding":1147282512,"approxSaleDate":"2025-12-09","exchange":"NYSE","filedAt":"2025-12-09"},{"accessionNo":"0001973379-25-000315","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Daniell Richard","relationship":"Officer, EXECUTIVE VP EUROPEAN COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":115468,"aggregateMarketValue":3311131.04,"unitsOutstanding":1147282512,"approxSaleDate":"2025-12-09","exchange":"NYSE","filedAt":"2025-12-09"},{"accessionNo":"0000902664-25-005163","issuerCik":"0000818686","issuerName":"Teva Pharmaceutical Industries Limited","ticker":"TEVA","personName":"Bridger Management, LLC (1)","relationship":"Shareholder","securityClass":"American Depositary Shares","broker":"Piper Sandler & Co.","unitsToSell":50000,"aggregateMarketValue":1249500,"unitsOutstanding":1147282512,"approxSaleDate":"2025-11-26","exchange":"NYSE","filedAt":"2025-11-26"},{"accessionNo":"0001973379-25-000296","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Fox Christine","relationship":"Officer, EVP HEAD OF US COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":28229,"aggregateMarketValue":699523.09,"unitsOutstanding":1147282512,"approxSaleDate":"2025-11-20","exchange":"NYSE","filedAt":"2025-11-20"},{"accessionNo":"0001973379-25-000292","issuerCik":"0000818686","issuerName":"TEVA PHARMACEUTICAL INDUSTRIES LTD","ticker":"TEVA","personName":"Fox Christine","relationship":"Officer, EVP HEAD OF US COMMERCIAL","securityClass":"ORDINARY SHARES","broker":"CITIGROUP GLOBAL MARKETS INC","unitsToSell":30000,"aggregateMarketValue":753321,"unitsOutstanding":1147282512,"approxSaleDate":"2025-11-14","exchange":"NYSE","filedAt":"2025-11-14"},{"accessionNo":"0000902664-25-004764","issuerCik":"0000818686","issuerName":"Teva Pharmaceutical Industries Limited","ticker":"TEVA","personName":"Bridger Management, LLC (1)","relationship":"Shareholder","securityClass":"American Depositary Shares(2)","broker":"Piper Sandler & Co.","unitsToSell":200000,"aggregateMarketValue":4920000,"unitsOutstanding":1147282512,"approxSaleDate":"2025-11-06","exchange":"NYSE","filedAt":"2025-11-06"}],"updatedAt":"2026-10-13T06:34:34.302Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}